{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:59:10Z","timestamp":1757620750034,"version":"3.44.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09092-9","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:56:04Z","timestamp":1753948564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Influencing Treatment Adherence in Chronic Spontaneous Urticaria: A Systematic Review"],"prefix":"10.1007","volume":"68","author":[{"given":"Aditya","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Gawey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raveena","family":"Ghanshani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khiem A.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Y.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"9092_CR1","doi-asserted-by":"crossref","unstructured":"Kolkhir P, Bonnekoh H, Metz M, Maurer M (2024) Chronic spontaneous urticaria: a review. JAMA [Internet] [cited 2024 Dec 12]332:1464\u201377. Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2824115","DOI":"10.1001\/jama.2024.15568"},{"key":"9092_CR2","doi-asserted-by":"crossref","unstructured":"Fricke J, \u00c1vila G, Keller T, Weller K, Lau S, Maurer M et al (2020) Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy [Internet] [cited 2024 Dec 12]75:423\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31494963\/","DOI":"10.1111\/all.14037"},{"key":"9092_CR3","doi-asserted-by":"crossref","unstructured":"Maurer M, Abuzakouk M, B\u00e9rard F, Canonica W, Oude Elberink H, Gim\u00e9nez-Arnau A et al (2017) The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy [Internet] [cited 2024 Dec 12]72:2005\u201316. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28543019\/","DOI":"10.1111\/all.13209"},{"key":"9092_CR4","doi-asserted-by":"crossref","unstructured":"Kolkhir P, Altrichter S, Asero R, Daschner A, Ferrer M, Gim\u00e9nez-Arnau A et al (2021) Autoimmune diseases are linked to type IIb autoimmune chronic spontaneous urticaria. Allergy Asthma Immunol Res [Internet] [cited 2024 Dec 12]13:545. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34212543\/","DOI":"10.4168\/aair.2021.13.4.545"},{"key":"9092_CR5","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D et al (2022) The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy [Internet] [cited 2024 Dec 13]77:734\u201366. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34536239\/"},{"key":"9092_CR6","unstructured":"(n.d.) Adherence to long-term therapies\u202f: evidence for action [Internet] [cited 2024 Dec 13]. Available from: https:\/\/iris.who.int\/handle\/10665\/42682"},{"key":"9092_CR7","doi-asserted-by":"crossref","unstructured":"C\u00eerstea N, Radu A, Vesa C, Radu AF, Bungau AF, Tit DM et al (2024) Current insights on treatment adherence in prevalent dermatological conditions and strategies to optimize adherence rates. Cureus [Internet] [cited 2024 Dec 13]16:e69764. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39429316\/","DOI":"10.7759\/cureus.69764"},{"key":"9092_CR8","doi-asserted-by":"crossref","unstructured":"Heng JK, Koh LJ, Toh MPHS, Aw DCW (2015) A study of treatment adherence and quality of life among adults with chronic urticaria in Singapore. Asia Pac Allergy [Internet] [cited 2024 Dec 14]5:197\u2013202. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26539401\/","DOI":"10.5415\/apallergy.2015.5.4.197"},{"key":"9092_CR9","first-page":"14898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 366:14898","journal-title":"BMJ."},{"key":"9092_CR10","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan ZE (2024) JBI manual for evidence synthesis. JBI Manual for Evidence Synthesis. JBI.","DOI":"10.46658\/JBIMES-24-01"},{"key":"9092_CR11","doi-asserted-by":"crossref","unstructured":"Maurer M, Ortonne JP, Zuberbier T (2009) Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients. Br J Dermatol [Internet] [cited 2024 Dec 13]160:633\u201341. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19014398\/","DOI":"10.1111\/j.1365-2133.2008.08920.x"},{"key":"9092_CR12","doi-asserted-by":"crossref","unstructured":"Weller K, Ziege C, Staubach P, Brockow K, Siebenhaar F, Krause K et al (2011) H1-antihistamine up-dosing in chronic spontaneous urticaria: patients\u2019 perspective of effectiveness and side effects--a retrospective survey study. PLoS One [Internet] [cited 2024 Oct 29]6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21909407\/","DOI":"10.1371\/journal.pone.0023931"},{"key":"9092_CR13","doi-asserted-by":"crossref","unstructured":"Hoskin B, Ortiz B, Paknis B, Kavati A (2019) Humanistic burden of refractory and nonrefractory chronic idiopathic urticaria: a real-world study in the United States. Clin Ther [Internet] [cited 2024 Dec 13]41:205\u201320. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30606639\/","DOI":"10.1016\/j.clinthera.2018.12.004"},{"key":"9092_CR14","doi-asserted-by":"crossref","unstructured":"Maurer M, Staubach P, Raap U, Richter-Huhn G, Baier-Ebert M, Chapman-Rothe N (2016) ATTENTUS, a German online survey of patients with chronic urticaria highlighting the burden of disease, unmet needs and real-life clinical practice. Br J Dermatol [Internet] [cited 2024 Dec 13]174:892\u20134. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26406483\/","DOI":"10.1111\/bjd.14203"},{"key":"9092_CR15","doi-asserted-by":"crossref","unstructured":"Hoskin B, Ortiz B, Paknis B, Kavati A (2019) Exploring the real-world profile of refractory and non-refractory chronic idiopathic urticaria in the USA: clinical burden and healthcare resource use. Curr Med Res Opin [Internet] [cited 2024 Dec 13]35:1387\u201395. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30793986\/","DOI":"10.1080\/03007995.2019.1586222"},{"key":"9092_CR16","doi-asserted-by":"crossref","unstructured":"Olga\u00e7 M, Ye\u011fit OO, Beyaz \u015e, \u00d6ztop N, T\u00fczer C, Eyice D et al (2023) Impact of COVID-19 pandemic on the course of refractory chronic spontaneous urticaria under omalizumab treatment. An Bras Dermatol [Internet] [cited 2024 Dec 13]98:189\u201397. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36609081\/","DOI":"10.1016\/j.abd.2022.08.006"},{"key":"9092_CR17","doi-asserted-by":"crossref","unstructured":"Podder I, Das A, Ghosh S, Biswas D, Sengupta S, Chowdhury SN (2020) Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: a double-blind, parallel group, randomized controlled trial. Dermatol Ther [Internet] [cited 2024 Nov 10]33. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32618048\/","DOI":"10.1111\/dth.13946"},{"key":"9092_CR18","doi-asserted-by":"crossref","unstructured":"Camarasa JMG, Aliaga A, Fern\u00e1ndez-Vozmediano JM, Fonseca E, Iglesias L, Tagarro I (2001) Azelastine tablets in the treatment of chronic idiopathic urticaria: phase III, randomised, double-blind, placebo and active controlled multicentric clinical trial. Skin Pharmacol Appl Skin Physiol [Internet] [cited 2024 Oct 29]14:77\u201386. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11316966\/","DOI":"10.1159\/000056337"},{"key":"9092_CR19","doi-asserted-by":"crossref","unstructured":"Denman S, El-Shanaway T, Carne E, Devlin L, Savic S (2020) Multicentre experience of home omalizumab treatment for chronic spontaneous urticaria. Eur J Hosp Pharm [Internet] [cited 2024 Nov 7]27:367\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33097621\/","DOI":"10.1136\/ejhpharm-2019-001914"},{"key":"9092_CR20","doi-asserted-by":"crossref","unstructured":"Ghazanfar MN, Holm JG, Thomsen SF (2018) Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study. J Eur Acad Dermatol Venereol [Internet] [cited 2024 Nov 7]32:1761\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29729103\/","DOI":"10.1111\/jdv.15045"},{"key":"9092_CR21","doi-asserted-by":"crossref","unstructured":"Lapeere H, Baeck M, Stockman A, Sabato V, Grosber M, Moutschen M et al (2019) A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real\u2010world study in Belgium. J Eur Acad Dermatol Venereol [Internet] [cited 2024 Nov 7]34:127. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7003755\/","DOI":"10.1111\/jdv.15684"},{"key":"9092_CR22","doi-asserted-by":"crossref","unstructured":"Ke X, Kavati A, Wertz D, Huang Q, Wang L, Willey VJ et al (2018) Real-world characteristics and treatment patterns in patients with urticaria initiating omalizumab in the United States. J Manag Care Spec Pharm [Internet] [cited 2024 Nov 6]24:598\u2013606b. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29952712\/","DOI":"10.18553\/jmcp.2018.24.7.598"},{"key":"9092_CR23","doi-asserted-by":"crossref","unstructured":"Bishnoi A, Parsad D, Vinay K, Kumaran MS (2017) Phototherapy using narrowband ultraviolet B and psoralen plus ultraviolet A is beneficial in steroid-dependent antihistamine-refractory chronic urticaria: a randomized, prospective observer-blinded comparative study. Br J Dermatol [Internet] [cited 2024 Dec 14]176:62\u201370. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27258736\/","DOI":"10.1111\/bjd.14778"},{"key":"9092_CR24","doi-asserted-by":"crossref","unstructured":"Datta A, Chandra S, Saha A, Sil A, Das N (2020) Exploring the safety and effectiveness of subcutaneous autologous serum therapy versus conventional intramuscular autologous serum therapy in chronic urticaria: an observer-blind, randomized, controlled study. Indian J Dermatol Venereol Leprol [Internet] [cited 2024 Nov 7]86:632\u201342. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33063705\/","DOI":"10.4103\/ijdvl.IJDVL_577_19"},{"key":"9092_CR25","doi-asserted-by":"crossref","unstructured":"Shi Y zhou, Yu S guang, Zheng H, Zheng Q hua, Zhou S yuan, Huang Y et al (2023) Acupuncture for patients with chronic spontaneous urticaria: a randomized, sham-controlled pilot trial. Chin J Integr Med [Internet] [cited 2024 Dec 14]29:924\u201331. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37561282\/","DOI":"10.1007\/s11655-023-3741-x"},{"key":"9092_CR26","doi-asserted-by":"crossref","unstructured":"Rimoldi M, Rossi O, Rota N (2016) State of the art of chronic spontaneous urticaria in Italy: a multicentre survey to evaluate physicians\u2019 and patients\u2019 perspectives. BMJ Open [Internet] [cited 2024 Dec 14]6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27742625\/","DOI":"10.1136\/bmjopen-2016-012378"},{"key":"9092_CR27","doi-asserted-by":"publisher","DOI":"10.5455\/medscience.2021.02.044","volume":"10","author":"G Aytekin","year":"2021","unstructured":"Aytekin G, Atayik E (2021) The effect of COVID-19 pandemic on treatment compliance and process of chronic urticaria patients receiving omalizumab treatment. Med Sci 10:764","journal-title":"Med Sci"},{"key":"9092_CR28","doi-asserted-by":"crossref","unstructured":"Erdem Y, Polat Ekinci A, Altunay IK, Sivaz O, Inal S, Gokalp MO et al (2021) The impact of COVID-19 pandemic on the management of patients with chronic urticaria: an observational two-center study from Turkey. Dermatol Ther [Internet] [cited 2024 Nov 10]34. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33301190\/","DOI":"10.1111\/dth.14652"},{"key":"9092_CR29","doi-asserted-by":"crossref","unstructured":"Williams P, Kavati A, Pilon D, Xiao Y, Zhdanava M, Balp MM et al (2018) Health care burden and treatment patterns in commercially insured children with chronic idiopathic\/spontaneous urticaria: a real-world study in the United States. Allergy Asthma Proc [Internet] [cited 2024 Dec 14]39:201\u201311. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29514728\/","DOI":"10.2500\/aap.2018.39.4129"},{"key":"9092_CR30","doi-asserted-by":"crossref","unstructured":"Akdogan N, Incel-Uysal P, Oktem A, Hayran Y, Yalcin B (2019) Educational level and job status are the most important factors affecting compliance with oral antihistamine therapy for patients with chronic urticaria. J Dermatolog Treat [Internet] [cited 2024 Nov 7]30:183\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29757034\/","DOI":"10.1080\/09546634.2018.1476651"},{"key":"9092_CR31","doi-asserted-by":"crossref","unstructured":"Calzari P, Chiei Gallo A, Barei F, Bono E, Cugno M, Marzano AV et al (2024) Omalizumab for the treatment of chronic spontaneous urticaria in adults and adolescents: an eight-year real-life experience. J Clin Med [Internet] [cited 2025 Jul 13]13:5610. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11432798\/","DOI":"10.3390\/jcm13185610"},{"key":"9092_CR32","doi-asserted-by":"crossref","unstructured":"Atik \u00d6, Tepetam FM, \u00d6zden \u015e, Kocat\u00fcrk E (2024) Eosinophilic cationic protein and D-Dimer are potential biomarkers to predict response to antihistamines but not to omalizumab in chronic spontaneous urticaria. Libyan J Med [Internet] [cited 2025 Jul 13]19:2420483. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11520092\/","DOI":"10.1080\/19932820.2024.2420483"},{"key":"9092_CR33","doi-asserted-by":"crossref","unstructured":"Pyatilova P, Hackler Y, Aulenbacher F, Asero R, Bauer A, Bizjak M et al (2024) Non\u2013skin related symptoms are common in chronic spontaneous urticaria and linked to active and uncontrolled disease: results from the chronic urticaria registry. J Allergy Clin Immunol: Pract [Internet] [cited 2025 Jul 13]12:1890\u20131899.e3. Available from: https:\/\/www.jaci-inpractice.org\/action\/showFullText?pii=S2213219824004124","DOI":"10.1016\/j.jaip.2024.04.027"},{"key":"9092_CR34","doi-asserted-by":"crossref","unstructured":"Stolz J, Salameh P, Asero R, Kocat\u00fcrk E, Peter J, Grattan C et al (2025) Parameters linked with higher itch severity in chronic spontaneous urticaria\u2014chronic urticaria registry results. J Allergy Clin Immunol: Pract [Internet] [cited 2025 Jul 13];0. Available from: https:\/\/www.jaci-inpractice.org\/action\/showFullText?pii=S2213219825004982","DOI":"10.1016\/j.jaip.2025.05.033"},{"key":"9092_CR35","unstructured":"(n.d.) Celldex presents unprecedented 76 week results from barzolvolimab phase 2 study in chronic spontaneous urticaria at EAACI Congress 2025 - Celldex Therapeutics [Internet]. [cited 2025 Jul 13]. Available from: https:\/\/ir.celldex.com\/news-releases\/news-release-details\/celldex-presents-unprecedented-76-week-results-barzolvolimab"},{"key":"9092_CR36","doi-asserted-by":"publisher","unstructured":"Metz M, Gim\u00e9nez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S et al (2025) Remibrutinib in chronic spontaneous urticaria. N Engl J Med 392:984\u201394. https:\/\/doi.org\/10.1056\/NEJMoa2408792.","DOI":"10.1056\/NEJMoa2408792"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09092-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09092-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:37:33Z","timestamp":1757327853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09092-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9092"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09092-9","relation":{},"ISSN":["1559-0267"],"issn-type":[{"type":"electronic","value":"1559-0267"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"assertion":[{"value":"25 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. As this study is based solely on publicly available data from previously published studies, ethics approval and informed consent were not required. No human participants were directly involved, and no identifiable patient data were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"74"}}